Testican-1 Activators refers to a group of chemical compounds and substances that have demonstrated the capacity to directly or indirectly influence the activity or expression of Testican-1, a proteoglycan found in the extracellular matrix. Testican-1 is known to play a role in various biological processes, including cell adhesion, migration, and tissue remodeling. Activating or modulating Testican-1 through these chemical agents offers insights into the intricate regulatory mechanisms that govern the behavior of this protein and its interactions with other cellular components.
Testican-1 Activators encompass a diverse array of molecules that act upon different aspects of the molecular pathways involved in Testican-1 regulation. Some of these activators may target specific signaling pathways, such as the TGF-beta pathway or the MAPK/ERK pathway, which are known to be linked to Testican-1 functions. These compounds may enhance or inhibit these signaling pathways to fine-tune the expression or activity of Testican-1. Additionally, Testican-1 Activators may influence Testican-1 indirectly by targeting processes like cell adhesion or matrix remodeling. For example, RGD peptides, a class of Testican-1 Activators, contain the RGD motif, promoting cell adhesion to extracellular matrix proteins, thereby indirectly modulating Testican-1's role in cell-matrix interactions. Similarly, matrix metalloproteinase (MMP) inhibitors, which fall under this class, work to prevent the degradation of the extracellular matrix, preserving Testican-1's structural integrity.
SEE ALSO...
Items 11 to 17 of 17 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
A JAK/STAT pathway inhibitor that may indirectly activate Testican-1 by affecting cell signaling related to extracellular matrix components through the JAK/STAT pathway. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Another JAK/STAT inhibitor that indirectly influences Testican-1 by modulating the JAK/STAT pathway, which can impact cell signaling and interactions with the extracellular matrix. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A Rho kinase inhibitor that may indirectly activate Testican-1 by affecting cytoskeletal dynamics, cell motility, and processes related to Testican-1 activation within the extracellular matrix. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Another Rho kinase inhibitor that indirectly influences Testican-1 by modulating the Rho kinase pathway, which can impact cytoskeletal dynamics and cell motility, activating Testican-1 interactions. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $75.00 $121.00 | 33 | |
An EGFR inhibitor that may indirectly activate Testican-1 by influencing cell signaling and adhesion to the extracellular matrix, processes in which Testican-1 is involved. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Another EGFR inhibitor that indirectly influences Testican-1 by modulating EGFR-related cell signaling and adhesion to the extracellular matrix, activating Testican-1 interactions. | ||||||
4-Methylumbelliferone | 90-33-5 | sc-206910 sc-206910A sc-206910B sc-206910C sc-206910D | 25 g 100 g 250 g 1 kg 2.5 kg | $35.00 $56.00 $141.00 $431.00 $973.00 | 2 | |
A hyaluronidase inhibitor that may indirectly activate Testican-1 by stabilizing hyaluronic acid in the extracellular matrix, influencing Testican-1 activation and interactions with the matrix components. | ||||||